Comic Book Artist J.G. Jones on His Project Illustrating Patients with Rare Blood Cancers

J.G. Jones is a renowned comic book artist, illustrating covers of beloved superhero novels like Batman and Robin, Doc Savage, and Frankenstein. He has probably worked for all of the…

Continue Reading Comic Book Artist J.G. Jones on His Project Illustrating Patients with Rare Blood Cancers
Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment
source: pixabay.com

Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment

According to a story from GlobeNewswire, the biopharmaceutical company Immunomedics, Inc., has recently announced that its medication sacituzumab govitecan-hziy (marketed as Trodelvy) has recently earned Orphan Drug designation from the…

Continue Reading Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment
Gene Therapy Receives Rare Pediatric Disease Designation for Sandhoff Disease and Tay-Sachs Disease
source: pixabay.com

Gene Therapy Receives Rare Pediatric Disease Designation for Sandhoff Disease and Tay-Sachs Disease

According to a story from GlobeNewswire, the gene therapy company Axovant Gene Therapies Ltd. recently announced that its gene therapy AXO-AAV-GM2 has been given Rare Pediatric Disease designation by the…

Continue Reading Gene Therapy Receives Rare Pediatric Disease Designation for Sandhoff Disease and Tay-Sachs Disease

30 New Genes Affiliated with Charcot Marie Tooth Disease Identified

Researchers have just uncovered 30 new genes that may cause Charcot-Marie-Tooth Disease (CMT).  These genes were uncovered using computer analyses of biological data, a process called bioinformatics. This study was published…

Continue Reading 30 New Genes Affiliated with Charcot Marie Tooth Disease Identified

Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes

A recent study published in BMC Rheumatology has found that a combination therapy could have a benefit for individuals diagnosed with diabetes and ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis…

Continue Reading Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes
Phase 3 SIDEROS Trial for DMD Drug Idebenone Fails
stevepb / Pixabay

Phase 3 SIDEROS Trial for DMD Drug Idebenone Fails

While many pharmaceutical companies submit approval and marketing applications, not all are successful. According to Fierce Biotech, a subsidiary of Questex, Santhera Pharmaceuticals ("Santhera"), is one of the most recent…

Continue Reading Phase 3 SIDEROS Trial for DMD Drug Idebenone Fails
Close Menu